
Celularity fell 72.6% from $1.71 to $0.47, behind the S&P 500's +9.7%. Its worst day was Aug 28 (−24.8%), and its low came Nov 19 at $0.47.
Nov 20, 2025 – Nov 19, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.85 was reported on $4.1M revenue.
+2.4% · S&P 500 +0.3%
Celularity shares rose 29.1%, while the S&P 500 rose 0.9%.
+29.1% · S&P 500 +0.9%
Story events cover the past 12 months · Times ET
Celularity closed at its highest level of the year, 22.8% above where the year started.
+138.5%, the year's best day, on 221M shares, the year's heaviest volume · S&P 500 +0.7%
EPS of $0.02 was reported on $3.8M revenue.
−1.5% · S&P 500 −0.2%
EPS of $0.02 was reported on $5.4M revenue.
−19.0% · S&P 500 +0.5%
Where it ended: a close of $0.47 on Nov 19, 2026. Up next: Q3 2026 earnings on Dec 1, 2026.
Nothing in the past 12 months.
All CELU analyst actionsNothing in the past 12 months.
All CELU dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CELU and SPY from Benzinga historical bars. Not investment advice.